dr charles wilson MB BS MD MRCP FRCR
Weekly Friday 14:00 - 17:00
Secretary: Kim McShane 01223 217110
Charles Wilson is a Consultant Clinical Oncologist at Cambridge University Hospitals (Addenbrooke's). He is the Clinical Lead for Breast Cancer services at Addenbrooke's.
Dr Wilson is a leading expert on breast, colorectal and anal malignancy. He has led the development of new radiotherapy techniques, most recently the radioembolisation with Yttrium particles for inoperable liver metastases resulting in Addenbrooke’s becoming a nationally accredited centre. He is the regional lead for the management of anal cancer, and he has been the local principal investigator for several national clinical trials in systemic therapy for breast and colorectal cancer.
He is a member and former chair of the NCIN Chemotherapy Clinical Information Group that oversees the UK national Systemic Anti-Cancer Therapy (SACT) dataset and is a member of the NHS England Chemotherapy Reference Group, advising the NHS on chemotherapy services. He also sits on the joint colleges National Chemotherapy Board. Dr Wilson was closely involved in the development of the Wallace cancer support care centre (now Maggies Wallace) and is the consultant representative for the Macmillan Cancer Information and Support Service in Cambridge.
Dr Wilson trained in Medicine at Westminster Hospital London and undertook his specialist training at the Hammersmith Hospital and the Royal Marsden Hospital. As an ICRF fellow he completed his MD research on Positron Emission Tomography at the MRC cyclotron unit London. He joined Addenbrooke’s as a Consultant Clinical Oncologist in 1993.
- University of London (Westminster)
- Hammersmith Hospital
- MRC Cyclotron unit, London
- Royal Marsden Hospital
- Consultant Clinical Oncologist
- MB BS, MD (London) MRCP (UK) FRCR (London)
GMC number: 2660260
- British Breast Group
- European Society for Radiation and Oncology
- National Chemotherapy Board
- Medical Defence Union